Your browser doesn't support javascript.
loading
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201).
Camm, A John; Piccini, Jonathan P; Alings, Marco; Dorian, Paul; Gosselin, Gilbert; Guertin, Marie-Claude; Ip, James E; Kowey, Peter R; Mondésert, Blandine; Prins, Fransisco J; Roux, Jean-Francois; Stambler, Bruce S; van Eck, Jwm; Al Windy, Nadea; Thermil, Nathalie; Shardonofsky, Silvia; Bharucha, David B; Roy, Denis.
  • Camm AJ; Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St. George's University of London, United Kingdom (A.J.C.).
  • Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (J.P.P.).
  • Alings M; Department of Cardiology, Amphie Hospital, Breda, the Netherlands (M.A.).
  • Dorian P; Division of Cardiology, Unity Health Toronto, Ontario, Canada (P.D.).
  • Gosselin G; Department of Medicine, Montreal Heart Institute, Québec, Canada (G.G., M.-C.G., B.M., D.R.).
  • Guertin MC; Department of Medicine, Montreal Heart Institute, Québec, Canada (G.G., M.-C.G., B.M., D.R.).
  • Ip JE; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital (J.E.I.).
  • Kowey PR; Cardiology Division and Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA (P.R.K.).
  • Mondésert B; Department of Medicine, Montreal Heart Institute, Québec, Canada (G.G., M.-C.G., B.M., D.R.).
  • Prins FJ; Elkerliek, Helmond, the Netherlands (F.J.P.).
  • Roux JF; Centre Hospitalier de l'Université de Sherbrooke, Québec, Canada (J.-F.R.).
  • Stambler BS; Piedmont Heart Institute, Atlanta, GA (B.S.S.).
  • van Eck J; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands (J.W.M.v.E.).
  • Al Windy N; Gelre Ziekenhuizen, Zutphen, the Netherlands (N.A.W.).
  • Thermil N; Milestone Pharmaceuticals, Montreal, Canada (N.T., S.S.).
  • Shardonofsky S; Milestone Pharmaceuticals, Montreal, Canada (N.T., S.S.).
  • Bharucha DB; Milestone Pharmaceuticals, Charlotte, NC (D.B.B.).
  • Roy D; Department of Medicine, Montreal Heart Institute, Québec, Canada (G.G., M.-C.G., B.M., D.R.).
Circ Arrhythm Electrophysiol ; 16(12): 639-650, 2023 12.
Article en En | MEDLINE | ID: mdl-37950726
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial Límite: Aged / Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial Límite: Aged / Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article